324: The AI Portfolio CEO: Kill Pilots, Fund Platforms and Measure Enterprise Value
The AI Portfolio CEO: Kill Pilots, Fund Platforms and Measure Enterprise Value
Artificial Intelligence is transforming the pharmaceutical industry—but many organizations remain trapped in endless AI pilots that never deliver measurable business value. In this episode of Center of Excellence – Pharma 4.0, we explore how executive leaders can shift from fragmented experimentation to enterprise-wide AI transformation.
In this episode, you’ll discover:
- Why AI pilot inflation is slowing enterprise transformation.
- The difference between AI pilots, AI platforms, and AI products.
- How CEOs and CFOs should prioritize investments and eliminate low-value initiatives.
- The importance of portfolio governance, decision gates, and capital discipline.
- Why successful AI requires business ownership—not just IT leadership.
- How to manage AI model drift, regulatory risk, vendor strategy, and continuous improvement.
- The five dimensions of enterprise AI value measurement.
- A practical 90-day executive roadmap to transition from scattered AI experiments to scalable enterprise platforms.
Whether you are a CEO, CIO, Chief Digital Officer, AI leader, pharmaceutical executive, or transformation professional, this episode provides a practical blueprint for building AI capabilities that create sustainable competitive advantage, improve operational performance, strengthen compliance, and deliver measurable enterprise value.
Tune in to learn why the future belongs not to organizations running the most AI pilots—but to those building the right AI platforms.
Resources:
Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB
Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/
Subscribe to our YouTube channel https://www.youtube.com/@COE-PHARMA4.0
Website: https://respa.com
and follow the Podcast https://pharma4coe.podbean.com for more insights on the future of Pharma!
#Pharma40 #ArtificialIntelligence #EnterpriseAI #GenerativeAI #DigitalTransformation #PharmaIndustry #AILeadership #AIStrategy #DigitalPharma #Innovation #AIGovernance #BusinessTransformation #LifeSciences #FutureOfWork #ExecutiveLeadership